Cite
APA Citation
Tyan, K., Bui, A., Giobbie-Hurder, A., Klein, I., Manos, M., Zubiri, L., Reynolds, K., Grover, S., Weinhouse, G., Ott, P., LeBoeuf, N., & Rahma, O. (n.d.). 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors. Journal for immunotherapy of cancer, 8, A296–A298. http://access.bl.uk/ark:/81055/vdc_100144722290.0x000003